125 related articles for article (PubMed ID: 18069274)
1. [Role of interferon for the treatment of myeloma].
Tomita S; Okamoto S
Nihon Rinsho; 2007 Dec; 65(12):2285-90. PubMed ID: 18069274
[TBL] [Abstract][Full Text] [Related]
2. [Role of interferon in the treatment of multiple myeloma].
Shimazaki C
Nihon Rinsho; 2006 Jul; 64(7):1291-6. PubMed ID: 16838647
[TBL] [Abstract][Full Text] [Related]
3. The role of alpha-interferon in multiple myeloma.
Peest D
Pathol Biol (Paris); 1999 Feb; 47(2):172-7. PubMed ID: 10192884
[TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha in the treatment of multiple myeloma.
Khoo TL; Vangsted AJ; Joshua D; Gibson J
Curr Drug Targets; 2011 Mar; 12(3):437-46. PubMed ID: 21143148
[TBL] [Abstract][Full Text] [Related]
5. Two dosage interferon-alpha 2b maintenance therapy in patients affected by low-risk multiple myeloma in plateau phase: a randomized trial.
Offidani M; Olivieri A; Montillo M; Rupoli S; Centurioni R; Alesiani F; Marchegiani G; Pieroni S; Catarini M; Pelliccia G; Altilia F; Leoni P
Haematologica; 1998 Jan; 83(1):40-7. PubMed ID: 9542322
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience.
Cohen AM; Meytes D; Many A; Brenner B; Aghai E; Shaklai M; Kaufman S; Shtalrid M; Attias D; Manor Y
Isr J Med Sci; 1995 Oct; 31(10):604-10. PubMed ID: 7591683
[TBL] [Abstract][Full Text] [Related]
7. Role of alpha interferon in multiple myeloma.
Joshua DE; MacCallum S; Gibson J
Blood Rev; 1997 Dec; 11(4):191-200. PubMed ID: 9481449
[TBL] [Abstract][Full Text] [Related]
8. Evolving role of novel agents for maintenance therapy in myeloma.
Magarotto V; Palumbo A
Cancer J; 2009; 15(6):494-501. PubMed ID: 20010169
[TBL] [Abstract][Full Text] [Related]
9. Viewpoint on the impact of interferon in the treatment of multiple myeloma: benefit for a small proportion of patients?
Bladé J; Esteve J
Med Oncol; 2000 May; 17(2):77-84. PubMed ID: 10871813
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Offidani M; Corvatta L; Polloni C; Piersantelli MN; Gentili S; Galieni P; Visani G; Alesiani F; Catarini M; Brunori M; Samori A; Burattini M; Centurioni R; Ferranti M; Giuliodori L; Candela M; Mele A; Marconi M; Leoni P
Br J Haematol; 2009 Mar; 144(5):653-9. PubMed ID: 19036082
[TBL] [Abstract][Full Text] [Related]
11. Interferon alpha in the therapy of multiple myeloma.
Gisslinger H
Leukemia; 1997 Dec; 11 Suppl 5():S52-6. PubMed ID: 9436940
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide maintenance therapy for patients with multiple myeloma: meta-analysis.
Kagoya Y; Nannya Y; Kurokawa M
Leuk Res; 2012 Aug; 36(8):1016-21. PubMed ID: 22579366
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma maintenance therapy: a review of the pharmacologic treatment.
Shank BR; Brown VT; Schwartz RN
J Oncol Pharm Pract; 2015 Feb; 21(1):36-51. PubMed ID: 24395544
[TBL] [Abstract][Full Text] [Related]
14. Interferon in multiple myeloma--summary of treatment results and clinical implications.
Ludwig H; Fritz E
Acta Oncol; 2000; 39(7):815-21. PubMed ID: 11145439
[TBL] [Abstract][Full Text] [Related]
15. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.
Spencer A; Prince HM; Roberts AW; Prosser IW; Bradstock KF; Coyle L; Gill DS; Horvath N; Reynolds J; Kennedy N
J Clin Oncol; 2009 Apr; 27(11):1788-93. PubMed ID: 19273705
[TBL] [Abstract][Full Text] [Related]
16. MRC trial of alpha2b-interferon maintenance therapy in first plateau phase of multiple myeloma. MRC Working Party on Leukaemia in Adults.
Drayson MT; Chapman CE; Dunn JA; Olujohungbe AB; Maclennan IC
Br J Haematol; 1998 Apr; 101(1):195-202. PubMed ID: 9576201
[TBL] [Abstract][Full Text] [Related]
17. Is alpha-interferon treatment in multiple myeloma worthwhile?
Avvisati G; Petrucci MT
Stem Cells; 1995 Aug; 13 Suppl 2():106-13. PubMed ID: 8520497
[TBL] [Abstract][Full Text] [Related]
18. Maintenance therapy for multiple myeloma with particular emphasis on thalidomide.
Dürk HA
Onkologie; 2006 Dec; 29(12):582-90. PubMed ID: 17202830
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib-thalidomide-based regimens improved clinical outcomes without increasing toxicity as induction treatment for untreated multiple myeloma: a meta-analysis of phase III randomized controlled trials.
Huang H; Zhou L; Peng L; Fu W; Zhang C; Hou J
Leuk Res; 2014 Sep; 38(9):1048-54. PubMed ID: 25052306
[TBL] [Abstract][Full Text] [Related]
20. Treatment of multiple myeloma: 2009 update.
Prescrire Int; 2009 Dec; 18(104):263-6. PubMed ID: 20025098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]